TY  - GEN
AU  - Cristóbal,Ion
AU  - Rodríguez,Marta
AU  - Cristóbal,Ion
AU  - Rodríguez,Marta
TI  - Molecular Pathways in Cancers
SN  - books978-3-0365-3681-1
PY  - 2022///
CY  - Basel
PB  - MDPI - Multidisciplinary Digital Publishing Institute
KW  - Medicine
KW  - bicssc
KW  - Oncology
KW  - actin cytoskeletal reorganization
KW  - breast cancer
KW  - CD99 agonist
KW  - EGFR dimerization
KW  - endocytosis
KW  - FAK dephosphorylation
KW  - PTPN12
KW  - Rac1
KW  - RhoA
KW  - tripeptide
KW  - OMD
KW  - PRELP
KW  - tumor suppression gene
KW  - bladder cancer initiation
KW  - tight junction
KW  - partial EMT
KW  - tousled-like kinase (TLK)
KW  - NIMA-related kinase 1 (NEK1)
KW  - yes-associated protein 1 (YAP1)
KW  - thioridazine (THD)
KW  - MS-determined phosphopeptides
KW  - human immunodeficiency virus type 1
KW  - epithelial cells
KW  - carcinogenicity
KW  - oxidative stress
KW  - reactive oxygen species
KW  - gp120
KW  - Tat
KW  - Nef
KW  - matrix protein p17
KW  - reverse transcriptase
KW  - mitochondria
KW  - metastasis
KW  - OXPHOS
KW  - cancer
KW  - Warburg effect
KW  - cancer therapeutics
KW  - myeloproliferative neoplasms
KW  - signaling pathways
KW  - JAK2
KW  - CALR
KW  - MPL
KW  - TPOR
KW  - DUSP1
KW  - MAPK
KW  - Snail
KW  - prostate cancer
KW  - migration and invasion
KW  - patient survival
KW  - biomarkers
KW  - pBRD4
KW  - SET
KW  - PP2A
KW  - prognosis
KW  - triple negative breast cancer
KW  - resistance
KW  - anti-receptor therapy
KW  - trastuzumab
KW  - PI3K
KW  - mTOR
KW  - TAK-228
KW  - epigenetic
KW  - methylation
KW  - acetylation
KW  - non-coding RNA
KW  - small-cell lung cancer
KW  - triple-negative breast cancer
KW  - pancreatic ductal adenocarcinoma
KW  - glioblastoma
KW  - metastatic melanoma
KW  - advanced ovarian cancer
KW  - hepatocellular carcinoma
KW  - immune evasion
KW  - immunotherapy
KW  - immune checkpoint inhibitors
KW  - oncogenic signaling pathway
KW  - molecular targeted agents
KW  - genome
KW  - epigenome
KW  - tumor immune microenvironment
KW  - ovarian cancer
KW  - adaptive immunity
KW  - innate immunity
KW  - complement system
KW  - cancer immunology
KW  - tumor microenvironment
KW  - splicing pathway
KW  - luminal breast cancer
KW  - BET inhibitors
KW  - n/a
N1  - Open Access
N2  - This book includes some recent works providing the readers with novel relevant findings about the main signaling pathways that govern the molecular pathogenesis of some of the highest prevalent human tumors, which are the basis for developing alternative therapeutic strategies to improve patient outcomes
UR  - https://mdpi.com/books/pdfview/book/5234
UR  - https://directory.doabooks.org/handle/20.500.12854/81202
ER  -